INTRODUCTION
Obesity is a serious healthcare problem world-wide and particularly in Spain. It is a risk factor for diabetes, cardiovascular and musculoskeletal diseases, gynecological problems and cancer. When conservative methods of treatment for obesity fail, bariatric surgery (BS) remains the only effective method of effective reduction of weight.
OBJECTIVE
To evaluate the cost-effectiveness of bariatric surgery compared with conservative medical management (CMM) for the treatment of morbidly obese patients from the Spanish National Healthcare System (NHS) perspective.
METHODS
A state-transition Markov model was developed 1 , in which morbidly obese patients may undergo surgery [consisting in a mix of techniques: gastric bypass (76%), sleeve gastrectomy (22%) and adjustable gastric banding (2%)] or continue with CMM. Patients may experience post-surgery complications, no complications, cardiovascular diseases, develop or recover from diabetes mellitus type 2 or die ( Figure 1) .
A base-case analysis was performed for the population of real surgical candidates in Spain (Table 1) . 2 Transition probabilities were obtained from national and international published registries: RICIBA, (perioperative mortality), 4 SOREG (effectiveness of surgery and long-term complications) 5 and the Hospital of Pontevedra for perioperative complications 2 . BS´s effect was determined by the change in the level of body mass index (BMI), systolic blood pressure (SBP), incidence and resolution of diabetes after surgery ( Table 2) .
Incidence of cardiovascular events 3 were determined using Framingham risk prediction algorithms. Incidence and remission from diabetes, changes of SBP using the Swedish Obesity Subject (SOS) 3 . Spanish mortality tables were used to account for normal mortality in the population 10 .
Utility values used depended on the BMI level and presence of diabetes 11 . Additionally, disutility of having cardiovascular conditions was considered.
Resource use and cost data were obtained from Spanish sources and expressed in €2014 (Table 3) . Direct medical costs and outcomes were discounted at a rate of 3%.
Deterministic and probabilistic sensitivity analyses were performed to assess the robustness of the model.
RESULTS
In the base-case analysis, BS led to a significant reduction in the incidence of diabetes and cardiovascular diseases (Table 4) .
Over life-time, BS was associated with an increase of 0.7 LY and 4.4 QALYs gained and with estimated average cost savings of € 740, resulting in BS being dominant over CMM (Table 5) .
PSA confirmed these results, being cost-effective in 99% of cases under the willingness-topay threshold of € 10,000/QALY) ( Figure 2 ).
One-to three-year delay in providing surgery instead of providing surgery immediately may lead to significant losses of clinical benefits, although it leads to cost reductions for the Spanish Healthcare System (Figure 3 ).
CONCLUSIONS
In a comprehensive decision analytic model, the current mix of bariatric surgical methods is a dominant option over conservative medical management in the treatment of morbidly obese patients over lifetime in Spain. Bariatric surgery led to a reduction in the incidence of severe diseases such as diabetes or cardiovascular disease.
However, delays in providing surgery may reduce these clinical benefits at the expense of slightly cost reduction for the NHS. This study was sponsored by Covidien AG (now a Medtronic company). Synergus AB is a medtech consulting company based in Stockholm, Sweden. Authors state that sponsor did not participated or influenced the analysis of the present study or the interpretations of its results.
